With the BMS Oncology Co-Pay Program, commercially insured patients can have their co-pay reduced to as little as $25 per Opdivo® prescription.
With the BMS Oncology Co-Pay Program, commercially insured patients can have their co-pay reduced to as little as $25 per Opdivo® prescription.